ATE470435T1 - Verfahren zur auswahl von kationischen oder anionischen liposomen zur behandlung einer schleimhautmembran und diese enthaltendes set - Google Patents

Verfahren zur auswahl von kationischen oder anionischen liposomen zur behandlung einer schleimhautmembran und diese enthaltendes set

Info

Publication number
ATE470435T1
ATE470435T1 AT04799314T AT04799314T ATE470435T1 AT E470435 T1 ATE470435 T1 AT E470435T1 AT 04799314 T AT04799314 T AT 04799314T AT 04799314 T AT04799314 T AT 04799314T AT E470435 T1 ATE470435 T1 AT E470435T1
Authority
AT
Austria
Prior art keywords
mucosa
treatment
charged lipid
disorder
medicament
Prior art date
Application number
AT04799314T
Other languages
English (en)
Inventor
Yechezkel Barenholz
Abraham Rubinstein
Tareq Jubeh
Original Assignee
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res Dev Co filed Critical Yissum Res Dev Co
Application granted granted Critical
Publication of ATE470435T1 publication Critical patent/ATE470435T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
AT04799314T 2003-11-03 2004-11-03 Verfahren zur auswahl von kationischen oder anionischen liposomen zur behandlung einer schleimhautmembran und diese enthaltendes set ATE470435T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51631603P 2003-11-03 2003-11-03
PCT/IL2004/001005 WO2005041932A2 (en) 2003-11-03 2004-11-03 Method for selecting cationic or anionic liposomes for treatment of a mucosa membrane, and kit comprising the same

Publications (1)

Publication Number Publication Date
ATE470435T1 true ATE470435T1 (de) 2010-06-15

Family

ID=34549524

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04799314T ATE470435T1 (de) 2003-11-03 2004-11-03 Verfahren zur auswahl von kationischen oder anionischen liposomen zur behandlung einer schleimhautmembran und diese enthaltendes set

Country Status (5)

Country Link
US (1) US20070212403A1 (de)
EP (1) EP1694298B1 (de)
AT (1) ATE470435T1 (de)
DE (1) DE602004027655D1 (de)
WO (1) WO2005041932A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004233873B2 (en) 2003-04-25 2010-11-18 The Penn State Research Foundation Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
US20070087045A1 (en) * 2005-10-14 2007-04-19 Industrial Technology Research Institute Lipid carrier and method of preparing the same
WO2008087803A1 (ja) * 2007-01-16 2008-07-24 Hokkaido University 抗酸化成分を封入したイオントフォレーシス用リポソーム製剤
US20110250262A1 (en) * 2008-12-24 2011-10-13 Biomedcore, Inc. Method for producing liposome and method for dissolving cholesterol
WO2012112730A2 (en) * 2011-02-15 2012-08-23 Merrimack Pharmaceuticals, Inc. Compositions and methods for delivering nucleic acid to a cell
CN102192978B (zh) * 2011-03-15 2013-09-04 中国科学院武汉病毒研究所 评价作用于体内粘膜的药物和外源物安全性的方法及应用
TW202302073A (zh) * 2021-03-18 2023-01-16 予宇生技股份有限公司 包含帶電脂質的脂質製劑的組合物及製備方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0714865B2 (ja) * 1986-10-28 1995-02-22 武田薬品工業株式会社 リポソ−ム製剤およびその製造法
US4918063A (en) * 1987-02-17 1990-04-17 Board Of Regents, The University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract
WO1993014744A1 (en) * 1992-02-04 1993-08-05 Chiron Corporation Non-toxic lipid vaccine formulations
US20020039556A1 (en) * 1995-09-27 2002-04-04 Kari Dyvik Stabilised phospholipid compositions
JP4772958B2 (ja) * 1998-02-09 2011-09-14 ブラッコ・リサーチ・ソシエテ・アノニム 生物学的に活性な媒質の標的に向けた送達
US6872406B2 (en) * 2000-02-11 2005-03-29 Children's Hospital Research Foundation Fusogenic properties of saposin C and related proteins and polypeptides for application to transmembrane drug delivery systems
US6616944B2 (en) * 2000-03-08 2003-09-09 Medinnova Gesellschaft Fur Medizinsche Innovationen Aus Adkademischer Forschung Mbh Self-assembling colloidal carriers for protein delivery
GB0111279D0 (en) * 2001-05-10 2001-06-27 Nycomed Imaging As Radiolabelled liposomes
ATE494905T1 (de) * 2001-06-29 2011-01-15 Chugai Pharmaceutical Co Ltd Krebsimpfstoff mit einem krebs-antigen auf grundlage des produkts aus dem tumorunterdrückungsgen wt1 und einem kationischen liposom

Also Published As

Publication number Publication date
EP1694298B1 (de) 2010-06-09
US20070212403A1 (en) 2007-09-13
DE602004027655D1 (de) 2010-07-22
WO2005041932A3 (en) 2005-06-02
WO2005041932A2 (en) 2005-05-12
EP1694298A2 (de) 2006-08-30

Similar Documents

Publication Publication Date Title
ATE309802T1 (de) Verwendung von cyclopamine zur behandlung von psoriasis und anderen hauterkrankungen
DE502005010615D1 (de) Mittel zur behandlung von entzündlichen erkrankungen
PH12012502079A1 (en) Novel compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
ATE536855T1 (de) Gewebegerüste zusamensetzungen zur behandlung von zahnerkrankungen
BR0111591A (pt) Compostos, composição farmacêutica, e, métodos para elevar o nìvel de plasma do hormÈnio de crescimento em um mamìfero, para o tratamento de deficiência da secreção do hormÈnio de crescimento, para o tratamento do retardo do crescimento em crianças, para o tratamento de distúrbios metabólicos associados com a deficiência da secreção do hormÈnio de crescimento, em particular em pacientes idosos, e para promover a cura de ferimentos, recupeção de cirurgia ou recuperação de doenças debilitantes
BR112013005673A2 (pt) uso de lipase de ácido lisossomal para tratamento de deficiência de lipase de ácido lisossomal em pacientes
DE60320095D1 (de) Zusammensetzungen zur behandlung von hauterkrankungen
Yang et al. Sihler-stain study of buccal nerve distribution and its clinical implications
IL174525A0 (en) Medicamentously targeted local lipolysis
ATE470435T1 (de) Verfahren zur auswahl von kationischen oder anionischen liposomen zur behandlung einer schleimhautmembran und diese enthaltendes set
ATE260282T1 (de) Aromatische ester von camptothecinen und verfahren zur behandlung von krebserkrankungen
EA200400888A1 (ru) Фармацевтически приемлемые тельца, несущие фосфат глицерина
WO2023043870A8 (en) Chewing gum formulation of lsd and methods of use thereof
DE60140960D1 (de) Verwendung von serp-1 in kombination mit einem immunosuppressor zur behandlung von arthritis
BRPI0407693A (pt) uso de esteróides para preparação de formulações utilizáveis no tratamento de pessoas sofrendo de distúrbios oculares, bem como formulação assim obtidos
MX2023002350A (es) Composiciones y metodos para mejorar enfermedades y trastornos neurologicos.
ATE398456T1 (de) Verwendung von negativ-geladenen phospholipiden zur herstellung eines medikaments zur behandlung und/oder vorbeugung von makuladegeneration
ATE338558T1 (de) Verwendung von phosphoglyzeriden enthaltend phosphoglycero-ether zur behandlung neurodegenerativer erkrankungen in geistig schwer behinderten kindern
DE602004030661D1 (de) Verwendung von kahalalide verbindungen zur herstellung eines arzneimittels zur behandlung von psoriasis
ATE376425T1 (de) Verfahren zur behandlung bestimmter augenkrankheiten
WO2021034996A3 (en) Treatment of cardiovascular diseases
RU2446839C1 (ru) Способ комплексного лечения больных с воспалительными заболеваниями придаточных пазух носа
BR0308040A (pt) Composições farmacêuticas e cosméticas compreendendo plgf-1
RU2159638C2 (ru) Способ лечения очаговой алопеции у детей
Asilian et al. Scalp myiasis associated with advanced basal cell carcinoma

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties